Search
Patexia Research
Case number 2018-1225

Horizon Therapeutics, LLC v. Iancu > Documents

Date Field Doc. No.Description (Pages)
Apr 23, 2021 0 HORIZON THERAPEUTICS, LLC v. IANCU [RULE 36 JUDGMENT] [nonprecedential] (0)
Dec 2, 2019 70 Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [653283] [JAB] [Entered: 12/02/2019 04:13 PM] (0)
Oct 10, 2019 69 JUDGMENT. AFFIRMED. Issued pursuant to Federal Circuit Rule 36. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [641460] [JAB] [Entered: 10/10/2019 09:58 AM] (0)
Jul 11, 2019 68 Submitted after ORAL ARGUMENT by Robert Fritz Green for Horizon Therapeutics, LLC and Kakoli Caprihan for Iancu. Panel: Judge: Newman , Judge: Clevenger , Judge: Reyna. [620272] [JAB] [Entered: 07/11/2019 10:44 AM] (0)
Jun 17, 2019 66 Amended Entry of appearance for Kakoli Caprihan as principal counsel for Intervenor Iancu. Service: 06/17/2019 by email. [614581] [18-1225] [Kakoli Caprihan] [Entered: 06/17/2019 10:15 AM] (0)
Jun 17, 2019 67 Response to notice of oral argument from the Intervenor Iancu. [614585] [18-1225] [Kakoli Caprihan] [Entered: 06/17/2019 10:18 AM] (0)
Jun 13, 2019 65 **TEXT ONLY** ORDER granting motion to withdraw attorney [64] filed by Intervenor Iancu. Entry of Appearance for new principal counsel due 06/20/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [613869] [JAB] [Entered: 06/13/2019 11:28 AM] (0)
Jun 10, 2019 64 MOTION of Intervenor Iancu to withdraw counsel Lore A. Unt [Consent: not addressed]. Service: 06/10/2019 by email. [612734] [18-1225] [Kakoli Caprihan] [Entered: 06/10/2019 11:50 AM] (0)
Jun 7, 2019 63 CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [33], ERROR: The attorney information listed on the Entry of Appearance for Lore. A. Unt does not match the information listed on the attorney's user account. CORRECTION: Please promptly update to ensure the information with the PACER Service Center matches the entry of appearance. [612245] [JAB] [Entered: 06/07/2019 09:11 AM] (0)
May 28, 2019 62 Entry of appearance for Emer L. Simic as of counsel for Appellant Horizon Therapeutics, LLC. Service: 05/28/2019 by email. [609925] [18-1225] [Robert Green] [Entered: 05/28/2019 05:09 PM] (0)
May 28, 2019 61 Response to notice of oral argument from the Appellant Horizon Therapeutics, LLC. [609924] [18-1225] [Robert Green] [Entered: 05/28/2019 05:03 PM] (0)
May 22, 2019 60 Entry of appearance for Meredith H. Schoenfeld as of counsel for Intervenor Iancu. Service: 05/22/2019 by email. [608947] [18-1225] [Meredith Schoenfeld] [Entered: 05/22/2019 10:59 AM] (2)
May 21, 2019 59 NOTICE OF ORAL ARGUMENT. Panel: 1907H. Case scheduled Jul 11, 2019 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 402. Response to Notice of Oral Argument due: 06/17/2019. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [608688] [JAB] [Entered: 05/21/2019 01:25 PM] (2)
Feb 19, 2019 57 Notice from Appellant Horizon Therapeutics, LLC regarding conflicts with oral argument. Service: 02/19/2019 by email. [587150] [18-1225] [Robert Green] [Entered: 02/19/2019 04:13 PM] (3)
Feb 19, 2019 56 Notice from Intervenor Iancu regarding conflicts with oral argument. Service: 02/19/2019 by email. [587059] [18-1225] [Kakoli Caprihan] [Entered: 02/19/2019 02:03 PM] (2)
Feb 15, 2019 55 6 paper copies of the Intervenor Brief [43] received from Intervenor Iancu. [586434] [CJF] [Entered: 02/15/2019 02:10 PM] (0)
Feb 15, 2019 54 6 paper copies of the Appendix Brief (Vol. I - II) [50] received from Appellant Horizon Therapeutics, LLC. [586273] [CJF] [Entered: 02/15/2019 10:38 AM] (0)
Feb 15, 2019 53 6 paper copies of the Reply Brief [49] received from Appellant Horizon Therapeutics, LLC. [586254] [CJF] [Entered: 02/15/2019 09:57 AM] (0)
Feb 11, 2019 52 Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [584957] [SJ] [Entered: 02/11/2019 04:09 PM] (1)
Feb 11, 2019 51 Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(1). [584956] [SJ] [Entered: 02/11/2019 04:09 PM] (0)
Feb 7, 2019 50 MODIFIED ENTRY: APPENDIX FILED (2 vols.) for Appellant Horizon Therapeutics, LLC. Number of Pages: 926. Service: 02/07/2019 by email. [584130] --[compliance review complete - Edited 02/11/2019 by SMJ] [Robert Green] [Entered: 02/07/2019 02:42 PM] (931)
Jan 31, 2019 49 MODIFIED ENTRY: REPLY BRIEF FILED for Appellant Horizon Therapeutics, LLC. Number of Pages: 30. Service: 01/31/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [582557] --[compliance review complete - Edited 02/04/2019 by SMJ] [Matthew Phillips] [Entered: 01/31/2019 05:49 PM] (41)
Jan 16, 2019 48 Notice of Appointment of New Solicitor from Patent and Trademark Office. Service: 01/22/2019 by clerk. [579526] [SJ] [Entered: 01/22/2019 09:05 AM] (1)
Jan 11, 2019 47 **TEXT ONLY** ORDER granting motion to extend time to file reply brief [46] filed by Appellant Horizon Therapeutics, LLC. Reply brief is due 01/31/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [577694] [SJ] [Entered: 01/11/2019 01:57 PM] (0)
Jan 9, 2019 46 MOTION of Appellant Horizon Therapeutics, LLC to extend the time to 01/31/2019 to file the 01/17/2019. [Consent: unopposed]. Service: 01/09/2019 by email. [577138] [18-1225] [Matthew Phillips] [Entered: 01/09/2019 05:50 PM] (8)
Dec 11, 2018 45 **TEXT ONLY** ORDER granting motion to extend time to file reply brief [44] filed by Appellant Horizon Therapeutics, LLC. Reply brief is due 01/17/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [570943] [SJ] [Entered: 12/11/2018 02:47 PM] (0)
Dec 10, 2018 44 MOTION of Appellant Horizon Therapeutics, LLC to extend the time to 01/17/2019 to file the Reply brief. [Consent: unopposed]. Service: 12/10/2018 by email. [570489] [18-1225] [Matthew Phillips] [Entered: 12/10/2018 01:18 PM] (8)
Dec 6, 2018 43 MODIFIED ENTRY: BRIEF FILED for Intervenor Iancu. Number of Pages: 56. Service: 12/06/2018 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [570060] --[compliance review complete - Edited 12/11/2018 by SMJ] [Lore Unt] [Entered: 12/06/2018 07:38 PM] (68)
Nov 21, 2018 42 **TEXT ONLY** ORDER granting motion to extend time to file brief [41] filed by Intervenor Iancu. Intervenor brief is due 12/05/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [567208] [JB] [Entered: 11/21/2018 03:14 PM] (0)
Nov 14, 2018 41 MOTION of Intervenor Iancu to extend the time to 12/05/2018 to file the Intervenor's opposition brief. [Consent: unopposed]. Service: 11/14/2018 by email. [564930] [18-1225] [Lore Unt] [Entered: 11/14/2018 04:07 PM] (5)
Nov 1, 2018 40 Entry of appearance for Kakoli Caprihan as of counsel for Intervenor Iancu. Service: 11/01/2018 by email. [561882] [18-1225] [Kakoli Caprihan] [Entered: 11/01/2018 11:36 AM] (2)
Oct 19, 2018 39 **TEXT ONLY** ORDER granting motion to extend time to file brief [38] filed by Intervenor Iancu. Intervenor brief due 11/21/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [558866] [SJ] [Entered: 10/19/2018 04:41 PM] (0)
Oct 17, 2018 38 MOTION of Intervenor Iancu to extend the time to 11/21/2018 to file the Director's Opening Brief. [Consent: unopposed]. Service: 10/17/2018 by email. [558065] [18-1225] [Lore Unt] [Entered: 10/17/2018 12:40 PM] (5)
Oct 10, 2018 37 Amended Certificate of Interest for the Appellant Horizon Therapeutics, LLC. Service: 10/10/2018 by email. [556172] [18-1225] [Robert Green] [Entered: 10/10/2018 05:01 PM] (4)
Sep 20, 2018 36 **TEXT ONLY** ORDER granting motion to extend time to file brief [35] filed by Intervenor Iancu. Intervenor brief due 10/24/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [551485] [SJ] [Entered: 09/20/2018 03:59 PM] (0)
Sep 17, 2018 35 MOTION of Intervenor Iancu to extend the time to 10/24/2018 to file the Director's Brief. [Consent: unopposed]. Service: 09/17/2018 by email. [550401] [18-1225] [Lore Unt] [Entered: 09/17/2018 03:09 PM] (4)
Sep 14, 2018 34 Docketing Statement for the Intervenor Iancu. Service: 09/14/2018 by email. [549749] [18-1225] [Lore Unt] [Entered: 09/14/2018 10:33 AM] (3)
Aug 21, 2018 33 Entry of appearance for Lore A. Unt as principal counsel for Intervenor Iancu. Service: 08/21/2018 by email. [544276] [18-1225] [Lore Unt] [Entered: 08/21/2018 10:30 AM] (2)
Aug 15, 2018 32 Official caption revised to reflect intervention of Andrei Iancu - Director of the United States Patent and Trademark Office. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Docketing Statement for Intervenor is due by 09/14/2018. Service as of this date by the Clerk of Court. [542934] [CMP] [Entered: 08/15/2018 09:52 AM] (0)
Aug 13, 2018 28 Notice of Intervention pursuant to the provisions of 35 USC Section 143 from the Director of the United States Patent and Trademark Office. Service: 08/13/2018 by email. [542459] [18-1225] [Farheena Rasheed] [Entered: 08/13/2018 03:12 PM] (3)
Aug 13, 2018 29 Entry of appearance for Farheena Y. Rasheed as principal counsel for Andrei Iancu, Intervenor-Director of the United States Patent and Trademark Office. Service: 08/13/2018 by email. [542463] [18-1225] [Farheena Rasheed] [Entered: 08/13/2018 03:14 PM] (2)
Aug 13, 2018 30 Entry of appearance for Joseph Matal as of counsel for Andrei Iancu, Intervenor-Director of the United States Patent and Trademark Office. Service: 08/13/2018 by email. [542466] [18-1225] [Joseph Matal] [Entered: 08/13/2018 03:17 PM] (2)
Aug 13, 2018 31 Entry of appearance for Thomas W. Krause as of counsel for Andrei Iancu, Intervenor - Director of the United States Patent and Trademark Office. Service: 08/13/2018 by email. [542468] [18-1225] [Thomas Krause] [Entered: 08/13/2018 03:19 PM] (2)
Jul 12, 2018 27 ORDER filed. The motion [26] is granted. The revised official caption and short caption are reflected in this order. The Director of the United States Patent and Trademark Office is directed to inform the court within 30 days of the date of filing of this order whether he intends to intervene in this appeal. If the Director elects to participate as intervenor, his brief is due within 40 days of the date of filing of his notice. Horizon Therapeutics, LLC may file its reply brief within 14 days of the date of filing of the Director’s brief. If the Director elects not to participate, Horizon Therapeutics shall file its appendix within 10 days of the date of filing of the Director's notice. Service: 07/12/2018 by clerk. [535320] [LMS] [Entered: 07/12/2018 09:11 AM] (2)
Jul 9, 2018 26 MOTION of Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc. to withdraw party, Appellees Lupin Ltd.'s and Lupin Pharmaceuticals, Inc., as a party to this appeal [Consent: unopposed]. Service: 07/09/2018 by email. [534564] [18-1225] [William Jay] [Entered: 07/09/2018 04:31 PM] (6)
Jul 9, 2018 25 Notice of Rejection to Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc., the following document(s): motion to withdraw party [24] is REJECTED for filing. Reason: missing certificate of interest. Service: 07/09/2018 by clerk. [534308] [CMP] [Entered: 07/09/2018 10:43 AM] (1)
Jul 6, 2018 24 MOTION of Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc. to withdraw party, Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc., as a party to this appeal [Consent: unopposed]. Service: 07/06/2018 by email. [534011] [18-1225] [William Jay] [Entered: 07/06/2018 10:58 AM] (4)
Apr 30, 2018 23 **TEXT ONLY** ORDER granting motion to extend time to file brief [22] filed by Appellees Lupin Pharmaceuticals, Inc. and Lupin Ltd. Brief due 07/18/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [517776] [CFT] [Entered: 04/30/2018 03:22 PM] (0)
Apr 30, 2018 22 MOTION of Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc. to extend the time to 07/18/2018 to file the response brief. [Consent: unopposed]. Service: 04/30/2018 by email. [517670] [18-1225] [William Jay] [Entered: 04/30/2018 10:47 AM] (8)
Apr 18, 2018 21 6 paper copies of the Opening Brief [20] received from Appellant Horizon Therapeutics, LLC. [515092] [JCP] [Entered: 04/19/2018 08:10 AM] (0)
Apr 9, 2018 20 BRIEF FILED for Appellant Horizon Therapeutics, LLC [18]. Number of Pages: 61. Service: 04/09/2018 by email. The paper copies of the brief should be received by the court on or before 04/19/2018. Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc. brief is due 05/21/2018. [512843] [JB] [Entered: 04/12/2018 12:04 PM] (137)
Apr 9, 2018 19 Amended Certificate of Interest for the Appellant Horizon Therapeutics, LLC. Service: 04/09/2018 by email. [511891] [18-1225] [Caryn Borg-Breen] [Entered: 04/09/2018 09:52 PM] (4)
Apr 9, 2018 18 TENDERED from Appellant Horizon Therapeutics, LLC. Title: OPENING BRIEF. Service: 04/09/2018 by email. [511890] [18-1225] [Caryn Borg-Breen] [Entered: 04/09/2018 09:50 PM] (137)
Feb 23, 2018 17 REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a) and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [500810] [CMP] [Entered: 02/23/2018 04:08 PM] (0)
Feb 13, 2018 16 **TEXT ONLY** ORDER granting motion to extend time to file appellant/petitioner principal brief [15] filed by Appellant Horizon Therapeutics, LLC. Brief due 04/09/2018. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [497433]--[Edited 02/14/2018 by SJ to correct due date] [CMP] [Entered: 02/13/2018 03:57 PM] (0)
Feb 13, 2018 15 MOTION of Appellant Horizon Therapeutics, LLC to extend the time to 04/09/2018 to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 02/13/2018 by email. [497426] [Robert Green] [Entered: 02/13/2018 03:49 PM] (8)
Jan 9, 2018 14 Certified list from the United States Patent and Trademark Office. Service: 01/08/2018 by. Appellant's brief is due 03/09/2018. [488157] [CMP] [Entered: 01/09/2018 09:22 AM] (43)
Dec 11, 2017 13 Docketing Statement for the Appellant Horizon Therapeutics, LLC. Service: 12/11/2017 by email. [481816] [Robert Green] [Entered: 12/11/2017 08:00 PM] (4)
Dec 11, 2017 12 Certificate of Interest for the Appellant Horizon Therapeutics, LLC. Service: 12/11/2017 by email. [481814] [Robert Green] [Entered: 12/11/2017 07:59 PM] (3)
Dec 11, 2017 11 Entry of appearance for Matthew C. Phillips as of counsel for Appellant Horizon Therapeutics, LLC. Service: 12/11/2017 by email. [481813] [Robert Green] [Entered: 12/11/2017 07:58 PM] (2)
Dec 11, 2017 10 Entry of appearance for Caryn C. Borg-Breen as of counsel for Appellant Horizon Therapeutics, LLC. Service: 12/11/2017 by email. [481811] [Robert Green] [Entered: 12/11/2017 07:57 PM] (2)
Dec 11, 2017 9 Entry of appearance for Robert F. Green as principal counsel for Appellant Horizon Therapeutics, LLC. Service: 12/11/2017 by email. [481810] [Robert Green] [Entered: 12/11/2017 07:56 PM] (2)
Dec 11, 2017 8 Certificate of Interest for the Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc.. Service: 12/11/2017 by email. [481805] [William Jay] [Entered: 12/11/2017 07:11 PM] (4)
Dec 11, 2017 7 Docketing Statement for the Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc.. Service: 12/11/2017 by email. [481803] [William Jay] [Entered: 12/11/2017 07:07 PM] (3)
Dec 11, 2017 6 Entry of appearance for Tiffany Mahmood as of counsel for Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc.. Service: 12/11/2017 by email. [481801] [Tiffany Mahmood] [Entered: 12/11/2017 07:01 PM] (2)
Dec 11, 2017 5 Entry of appearance for Robert V. Cerwinski as of counsel for Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc.. Service: 12/11/2017 by email. [481800] [Robert Cerwinski] [Entered: 12/11/2017 06:59 PM] (2)
Dec 11, 2017 4 Entry of appearance for Elizabeth J. Holland as of counsel for Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc.. Service: 12/11/2017 by email. [481799] [Elizabeth Holland] [Entered: 12/11/2017 06:57 PM] (2)
Dec 11, 2017 3 Entry of appearance for Cynthia Lambert Hardman as of counsel for Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc.. Service: 12/11/2017 by email. [481797] [Cynthia Hardman] [Entered: 12/11/2017 06:55 PM] (2)
Dec 11, 2017 2 Entry of appearance for William M. Jay as principal counsel for Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc.. Service: 12/11/2017 by email. [481796] [William Jay] [Entered: 12/11/2017 06:53 PM] (2)
Nov 27, 2017 1 Appeal docketed. Received: 11/22/2017. [478282] Entry of Appearance due 12/11/2017. Certificate of Interest is due 12/11/2017. Docketing Statement is due 12/11/2017. Certified List due 01/08/2018. [CMP] [Entered: 11/27/2017 03:27 PM] (40)
Menu